Double-Blind , Placebo-Controlled , Functional Neuroimaging Study of Armodafinil ( 200 mg/Day ) on Prefrontal Cortical Activation in Patients With Residual Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea .